Role of neutralizing antibodies in adults with community-acquired pneumonia by respiratory syncytial virus

Clinical Infectious Diseases

Volumn 54, Issue 7, 2012, Pages 905-912

  Luchsinger, Vivian ^a   Piedra, Pedro A ^b   Ruiz, Mauricio ^c   Zunino, Enna ^a   Martínez, María Angélica ^a   MacHado, Clarisse ^d   Fasce, Rodrigo ^e   Ulloa, María Teresa ^a   Fink, Maria Cristina ^d   Lara, Pamela ^a   Avendaño, Luis F ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e INSTITUTO DE SALUD PÚBLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BACTERIUM; BLOOD SAMPLING; CHILE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS ISOLATION; VIRUS NEUTRALIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHILE; CLINICAL LABORATORY TECHNIQUES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; PNEUMONIA, VIRAL; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84858118788     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir955     Document Type: Article

References (30)

1. Vila-Corcoles A, Ochoa-Gondar O, Rodr?́guez-Blanco T, Raga-Luria X, Gó mez-Bertomeu F. EPIVAC Study Group. Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir Med 2009; 103:309-16.
2. Johnstone J, Majumdar S, Fox J, Marrie T. Viral infection in adults hospitalized with community-acquired pneumonia. Chest 2008; 134: 1141-8.
3. Marcos MA, Esperatti M, Torres A. Viral pneumonia. Curr Op Infect Dis 2009; 22:143-7.
4. Falsey A. Respiratory syncytial virus infection in adults. Semin Respir Crit Care Med 2007; 28:171-81. (Pubitemid 46676911)
5. Falsey A, Hennessey P, Formica M, Cox C, Walsh E. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352:1749-59. (Pubitemid 40570923)
6. Jennings L, Anderson T, Beynon K, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 2008; 63: 42-8.
7. Johannson N, Kalin M, Tiveljung-Lindell A, Giske C, Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 2010; 50: 202-9.
8. Henrickson K, Breese C. Diagnostic assays for respiratory syncytial virus disease. Pediatr Infect Dis J 2007; 26:S36-40. (Pubitemid 350295028)
9. Templeton K, Scheltinga S, van den Eeden W, Graffelman W, van den Broek P, Claas E. Improved diagnosis of the etiology of communityacquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis 2005; 41:345-51. (Pubitemid 41022112)
10. Marcos MA, Camps M, Pumarola T, et al. The role of viruses in the aetiology of community-acquired pneumonia in adults. Antivir Ther 2006; 11:351-9. (Pubitemid 43823554)
11. Falsey A, Formica M, Walsh E. Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral cultures and serology in adults with respiratory illness. J Clin Microbiol 2002; 40:817-20. (Pubitemid 34208629)
12. Piedra P, Cron S, Jewell A, et al. Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Vaccine 2003; 21:2448-60. (Pubitemid 36561336)
13. Piedra P, Jewell A, Cron S, Atmar R, Glezen P. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine 2003; 21:3479-82. (Pubitemid 36792107)
14. Walsh E, Peterson D, Falsey A. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis 2004; 189: 233-8. (Pubitemid 38147246)
15. Fine M, Auble T, Yaely D, et al. A prediction rule to identify low risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-50. (Pubitemid 27044625)
16. Avendaño LF, Palomino MA, Larrañaga C. Surveillance for respiratory syncytial virus in infants hospitalized for acute lower respiratory infection in Chile (1989 to 2000). J Clin Microbiol 2003; 41:4879-82.
17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9. (Pubitemid 17064313)
18. Cane P, Pringle C. Molecular epidemiology of respiratory syncytial virus: rapid identification of subgroup A lineages. J Virol Methods 1992; 40:297-306.
19. Larrañaga C, Kajon A, Villagra E, Avendaño LF. Adenovirus surveillance on children hospitalized for acute lower respiratory infections in Chile (1988-1996). J Med Virol 2000; 60:342-6. (Pubitemid 30054290)
20. Escobar C, Luchsinger V, de Oliveira DB, Durigon E, Chnaiderman J, Avendaño LF. Genetic variability of human metapneumovirus isolated from Chilean children, 2003-2004. J Med Virol 2009; 81:340-4.
21. Esper F, Weibel C, Ferguson D, Landry ML, Kahn J. Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J Infect Dis 2005; 191:492-8. (Pubitemid 40216662)
22. Pitkäranta A, Arruda E, Maimberg H, Hayden FG. Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR. J ClinMicrobiol 1997; 35:1791-3. (Pubitemid 27255661)
23. Garc?́a D, Hiatt P, Jewell A, et al. Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosis. Pediatr Pulmonol 2007; 42:66-74. (Pubitemid 46080155)
24. Harmon M, Kendal A. Influenza viruses. In: Schmidt N, Emmons R, eds. Diagnostic procedures for viral, rickettsial and chlamydial infections. 6th ed. Washington, DC: APHA, 1989: 631-68.
25. Bartlett JG, Breiman RF, Mandell LA, File TM. Community acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998; 26:811-38. (Pubitemid 28180966)
26. Maass M, Bartels C, Kruger S, et al. Endovascular presence of Chlamydia pneumoniae DNA is a generalised phenomenon in atherosclerotic vascular disease. Atherosclerosis 1998; 140:S25-30. (Pubitemid 28535488)
27. Tjhie JH, Van Kuppeveld FJ, Roosendaal R, et al. Direct PCR enables detection of Mycoplasma pneumoniae in patients with respiratory tract infections. J Clin Microbiol 1994; 32:11-6. (Pubitemid 24016774)
28. Jonas D, Rosenbaum A, Weyrich S, Bhakdi S. Enzyme-linked immunoassay for detection of PCR-amplified DNA of Legionellae in bronchoalveolar fluid. J Clin Microbiol 1995; 33:1247-52.
29. Terrosi C, Di Genova G, Martorelli B, Valentini M, Cusi M. Humoral immunity to respiratory syncytial virus in young and elderly adults. Epidemiol Infec 2009; 137:1684-6.
30. Chen M, Chang J, Nason M, et al. A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate. J Immunol Methods 2010; 362:180-4.